ILMN — ILLUMINA, INC.
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1110803 ·
Last close
$271.90
Market Cap
$41.06B
52W High
$277.95
52W Low
$88.00
ADV30
3,317,796
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 1,091,000,000 | 721,000,000 | 209,000,000 | 134,000,000 | 6,559,000,000 | 1,089,000,000 | 3,883,000,000 |
| Dec 2025 | 1,159,000,000 | 759,000,000 | 211,000,000 | 334,000,000 | 6,644,000,000 | 1,418,000,000 | 3,921,000,000 |
| Sep 2025 | 1,084,000,000 | 733,000,000 | 227,000,000 | 150,000,000 | 6,177,000,000 | 1,050,000,000 | 3,796,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,128,000,000
Investing CF
$-358,000,000
Financing CF
$-800,000,000
CapEx
$-154,000,000
Dividends Paid
—
Buybacks
$-784,000,000
EPS Diluted TTM
$5.36
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-258,000,000
Inventory
$611,000,000
Receivables
$738,000,000
ST Investments
$66,000,000
EBIT TTM
$1,160,000,000
Pretax Income TTM
$1,060,000,000
Interest Exp TTM
$100,000,000
Analysts
19
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,494,000,128
EBITDA
$1,155,000,064
Free Cash Flow
$797,625,024
Enterprise Value
$32,532,948,992
Total Cash
$1,168,000,000
Total Debt
$2,527,000,064
Shares Out
151,000,000
Trailing EPS
$5.37
Book Value
$18.80
ROE
32.3%
ROA
8.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,343,000,000 | 817,000,000 | 850,000,000 | 6,644,000,000 | 3,921,000,000 | 2,723,000,000 | 1,079,000,000 |
| Dec 2024 | 4,372,000,000 | 600,000,000 | -1,223,000,000 | 6,303,000,000 | 3,930,000,000 | 2,373,000,000 | 837,000,000 |
| Dec 2023 | 4,504,000,000 | -222,000,000 | -1,161,000,000 | 10,111,000,000 | 4,366,000,000 | 5,745,000,000 | 478,000,000 |
| Dec 2022 | 4,584,000,000 | 354,000,000 | -4,404,000,000 | 12,252,000,000 | 5,653,000,000 | 6,599,000,000 | 392,000,000 |
TTM Snapshot
Revenues TTM
$4,355,000,000
NetIncome TTM
$-3,734,000,000
OpCashFlow TTM
$0
Assets (Latest)
$6,644,000,000
Forward EPS
$6.10
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BMDPF | BANCA MONTE DEI PASCHI DI SIENA SPA | $40.44B | $13.31 | — |
| DIA | SPDR DOW JONES INDUSTRIAL AVERAGE ETF TRUST | $41.76B | $514.02 | — |
| LYV | Live Nation Entertainment, Inc. | $40.04B | $171.89 | — |
| TRI | THOMSON REUTERS CORP /CAN/ | $42.17B | $97.33 | — |
| JXAMY | JX Advanced Metals Corporation/ADR | $42.89B | $48.00 | — |
News headlines (Yahoo Finance, 1h cache)
Is the Options Market Predicting a Spike in Illumina Stock?
2026-09-28 16:03 · Yahoo
Illumina Stock Popped 7% to a 52-Week High. Here’s Where the Stock Goes From Here
2026-09-25 14:07 · Yahoo
Illumina (ILMN) Tests Valuation As Russell Index Removal Forces A Fresh Look
2026-09-25 08:10 · Yahoo
Illumina Stock Surges 94.9% YTD: What's Behind the Rally?
2026-09-24 13:45 · Yahoo
NICU Genetic Testing Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)
2026-09-22 15:54 · Yahoo
Illumina Stock Is Up 133% This Year. Here’s Where It Could Go Further.
2026-09-20 13:25 · Yahoo
Genomics Market Outlook 2026-2035 - Featuring Profiles of Illumina, Thermo Fisher Scientific, and Qiagen
2026-09-18 10:44 · Yahoo
Transcriptome Sequencing Market - Global Forecast to 2035; Bulk RNA-Seq Maintains Its Technology Market Lead
2026-09-10 11:03 · Yahoo
Dear Illumina Stock Fans, Mark Your Calendars for September 21
2026-09-09 14:32 · Yahoo
Pharmacogenomics Market Outlook 2026-2035 - Featuring Profiles of Thermo Fisher Scientific, Illumina, and Qiagen
2026-09-18 10:43 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.